product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Rabbit anti GAPDH (N-Terminal)
catalog :
AHP1628
quantity :
0.1 mg
price :
355 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunocytochemistry
more info or order :
Bio-Rad product webpage
citations: 4
Reference
Tong B, Wu A, Huang A, Dong R, Malampati S, Iyaswamy A, et al. Lysosomal TPCN (two pore segment channel) inhibition ameliorates beta-amyloid pathology and mitigates memory impairment in Alzheimer disease. Autophagy. 2021;:1-19 pubmed publisher
Chen S, Kumar S, Espada C, Tirumuru N, Cahill M, Hu L, et al. N6-methyladenosine modification of HIV-1 RNA suppresses type-I interferon induction in differentiated monocytic cells and primary macrophages. PLoS Pathog. 2021;17:e1009421 pubmed publisher
Antonucci J, Kim S, St Gelais C, Bonifati S, Li T, Buzovetsky O, et al. SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells. J Virol. 2018;92: pubmed publisher
St Gelais C, Kim S, Maksimova V, Buzovetsky O, Knecht K, Shepard C, et al. A Cyclin-Binding Motif in Human SAMHD1 Is Required for Its HIV-1 Restriction, dNTPase Activity, Tetramer Formation, and Efficient Phosphorylation. J Virol. 2018;92: pubmed publisher
image
image 1 :
Bio-Rad AHP1628 image 1
Western blot analysis of whole cell lysate from HeLa, human epithelial adenocarcinoma cells probed with Rabbit anti Human GAPDH (AHP1628) at 0.125(A), 0.25(B) and 0.5(C) ug/ml
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
Region :
(N-TERMINAL)
ProductCode :
AHP1628
Description :
Rabbit anti GAPDH (N-Terminal)
Specificity :
GAPDH
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB,P,IC
ApplicationTypes :
Western Blotting,Immunohistology - Paraffin,Immunocytochemistry
Cross Reactivities :
Mouse,Rat
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0005515,GO:0016020,GO:0004365,GO:0005829,GO:0005634,GO:0006094,GO:0006096,GO:0055114,GO:0050821,GO:0035605,GO:0035606,GO:0048471,GO:0051287,GO:0051402
GOTerms :
protein binding,membrane,glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity,cytosol,nucleus,gluconeogenesis,glycolysis,oxidation-reduction process,protein stabilization,peptidyl-cysteine S-nitrosylase activity,peptidyl-cysteine S-trans-nitrosylation,perinuclear region of cytoplasm,NAD binding,neuron apoptosis
Uniprot Accessions :
P04406
Gene :
GAPDH
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2597
Published Synonyms :
GLYCERALDEHYDE-3-PHOSPHATE Dehydrogenase
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
267
PriceEUR :
330
PriceUSD :
355 USD
PriceCHF :
359
PriceSEK :
3597
PriceNOK :
3615
PriceDKK :
2460
more info or order :
Bio-Rad product webpage
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.